RecruitingNCT05815628

Next-Generation-Sequencing Approach to Neutropenic Sepsis

Sponsor

Boris Böll

Enrollment

400 participants

Start Date

Jun 5, 2024

Study Type

OBSERVATIONAL

Conditions

Febrile Neutropenia

Summary

The aim of this prospective, observational, non-interventional, multi-centre study of the diagnostic use of DISQVER in neutropenic patients with FN is to provide further evidence of the efficacy of an NGS-based approach for detecting bloodstream infection in neutropenic patients.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying DISQVER for people with febrile neutropenia. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.